Company news
Arvinas, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Arvinas to Present Virtually at the Goldman Sachs 41st Annual Global Healthcare Conference
June 4, 2020
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader ARV-110 in Patients with Metastatic Castration-Resistant Prostate Cancer
May 28, 2020
Arvinas to Hold Virtual 2020 Annual Meeting of Stockholders
May 19, 2020
Arvinas Announces Updated Phase 1 Data Demonstrating Clinical Activity of PROTAC® Protein Degrader ARV-110 in Patients with Refractory Prostate Cancer
May 12, 2020
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
April 27, 2020
Arvinas Provides Update on Business Continuity Related to the Impact of the COVID-19 Pandemic
April 12, 2020
Arvinas to Present at the American Society of Clinical Oncology Annual Meeting
March 30, 2020
Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 15, 2020
Arvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference
November 26, 2019
Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
November 20, 2019
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
November 5, 2019
Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 3, 2019
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
October 22, 2019
Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit
October 16, 2019
Arvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological Disorders
October 1, 2019
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
September 30, 2019
Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants
June 3, 2019
Calls
The 5 newest of 8 calls. Every call is listed under its year.
- Arvinas (NASDAQ:ARVN) Q2 2026 Earnings Call
Aug 4, 2026
Transcript - Arvinas (NASDAQ:ARVN) Q1 2026 Earnings Call
May 12, 2026
Transcript - Arvinas (NASDAQ:ARVN) Q4 2025 Earnings Call
Feb 24, 2026
Transcript - Arvinas (NASDAQ:ARVN) Q3 2025 Earnings Call
Nov 5, 2025
Transcript - Arvinas (NASDAQ:ARVN) Q2 2025 Earnings Call
Aug 6, 2025
Transcript
Decks
The 5 newest of 19 decks. Every deck is listed under its year.
- Investor Presentation (August 2026)
Investor deck · 56 slides · August 2026
- Jefferies Global Healthcare Conference 2026
Conference · 8 slides · Jun 2, 2026
- Q4 2025 Earnings Presentation
Earnings · 74 slides · Feb 24, 2026
- Q2 2025 Earnings Presentation
Earnings · 70 slides · Aug 6, 2025
- Technical Presentation (June 2025)
Technical · 20 slides · Jun 2, 2025